{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:16:55Z","timestamp":1777418215783,"version":"3.51.4"},"reference-count":87,"publisher":"SAGE Publications","issue":"7-8","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To describe the rationale, principles, and dosage calculations for continuous-infusion \u03b2-lactam antibiotics to treat multidrug-resistant bacteria in patients undergoing continuous venovenous hemofiltration (CVVH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources:<\/jats:title>\n                    <jats:p>A MEDLINE search (1968\u2013November 2008) of the English-language literature was performed using the terms continuous infusion and Pseudomonas or Acinetobacter, hemofiltration or CVVH or hemodiafiltration or CVVHDF or continuous renal replacement therapy or pharmacokinetics; and terms describing different \u03b2-lactam antibiotics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study Selection and Data Extraction:<\/jats:title>\n                    <jats:p>In vitro, in vivo, and human studies were evaluated that used continuous-infusion \u03b2-lactam antibiotics to treat Pseudomonas aeruginosa and Acinetobacter baumannii infections. Studies were reviewed that described the pharmacokinetics of \u03b2-lactam antibiotics during CVVH as well as other modalities of continuous renal replacement therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Synthesis:<\/jats:title>\n                    <jats:p>Continuous infusion of \u03b2-lactam antibiotics, maintaining drug concentrations 4\u20135 times higher than the minimum inhibitory concentration, is a promising approach for managing infections caused by P. aeruginosa and A. baumannii. Safe yet effective continuous infusion therapy is made difficult by the occurrence of acute renal failure and the need for renal replacement therapy. Case series and pharmacokinetic properties indicate that several \u03b2-lactam antimicrobials that have been studied for continuous infusion, such as cefepime, ceftazidime, piperacillin, ticarcillin, clavulanic acid, and tazobactam, are significantly cleared by hemofiltralion. Methodology and formulas are provided that allow practitioners to calculate dosage regimens and reach target drug concentrations for continuous \u03b2-lactam antibiotic infusions during CVVH based on a literature review, pharmacokinetic principles, and our experience at the National Institutes of Health Clinical Center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Continuous infusion of \u03b2-lactam antibiotics may be a useful treatment strategy for multidrug-resistant gram-negative infections in the intensive care unit. Well-established pharmacokinetic and pharmacodynamic principles can be used to safely reach and maintain steady-state target concentrations of \u03b2-lactam antibiotics in critical illness complicated by acute renal failure requiring CVVH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1345\/aph.1l638","type":"journal-article","created":{"date-parts":[[2009,7,7]],"date-time":"2009-07-07T23:44:38Z","timestamp":1247010278000},"page":"1324-1337","source":"Crossref","is-referenced-by-count":36,"title":["Continuous-Infusion \u03b2-Lactam Antibiotics During Continuous Venovenous Hemofiltration for the Treatment of Resistant Gram-Negative Bacteria"],"prefix":"10.1177","volume":"43","author":[{"given":"Brad","family":"Moriyama","sequence":"first","affiliation":[{"name":"Clinical Pharmacist, Pharmacy Department, National Institutes of Health (NIH) Clinical Center, Bethesda, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey A","family":"Henning","sequence":"additional","affiliation":[{"name":"Clinical Pharmacist, Pharmacy Department, NIH Clinical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melinda M","family":"Neuhauser","sequence":"additional","affiliation":[{"name":"Clinical Pharmacist, US Department of Veteran Affairs, Pharmacy Benefits Management Services, Hines, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L","family":"Danner","sequence":"additional","affiliation":[{"name":"Critical Care Medicine Department, NIH Clinical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J","family":"Walsh","sequence":"additional","affiliation":[{"name":"Immunocompromised Host Section, Pediatric Oncology Branch, National Cancer Institute, Bethesda"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2009,7,7]]},"reference":[{"key":"bibr1-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1086\/499819"},{"key":"bibr2-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.17.3.297"},{"key":"bibr3-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1592\/phco.28.2.235"},{"key":"bibr4-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1086\/524891"},{"key":"bibr5-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1592\/phco.26.9.1320"},{"key":"bibr6-aph.1L638","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200666010-00001"},{"key":"bibr7-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg467"},{"key":"bibr8-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1086\/516284"},{"key":"bibr9-aph.1L638","first-page":"63","volume":"74","author":"Craig WA","year":"1991","journal-title":"Scand J Infect Dis Suppl"},{"key":"bibr10-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/15.suppl_A.201"},{"key":"bibr11-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1007\/BF02013630"},{"key":"bibr12-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1097\/MCC.0b013e3282e2a98f"},{"key":"bibr13-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70218-8"},{"key":"bibr14-aph.1L638","unstructured":"Bauer LA. Applied clinical pharmacokinetics. New York: McGraw-Hill, 2001: 39\u201341."},{"key":"bibr15-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/38.1.5"},{"key":"bibr16-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.5.931"},{"key":"bibr17-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.8.1797"},{"key":"bibr18-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1159\/000007198"},{"key":"bibr19-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh536"},{"key":"bibr20-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01433-06"},{"key":"bibr21-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/35.5.697"},{"key":"bibr22-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/47.5.617"},{"key":"bibr23-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh381"},{"key":"bibr24-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91741-2"},{"key":"bibr25-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90561-8"},{"key":"bibr26-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/40.1.125"},{"key":"bibr27-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1592\/phco.19.8.620.31525"},{"key":"bibr28-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1007\/PL00008370"},{"key":"bibr29-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200103270-00009"},{"key":"bibr30-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.20791"},{"key":"bibr31-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1C315"},{"key":"bibr32-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.07202.x"},{"key":"bibr33-aph.1L638","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199426060-00004"},{"key":"bibr34-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-6576.2001.450802.x"},{"key":"bibr35-aph.1L638","first-page":"307","volume":"8","author":"Golper TA","year":"1985","journal-title":"Int J Artif Organs"},{"key":"bibr36-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1159\/000420197"},{"key":"bibr37-aph.1L638","first-page":"S165","volume":"66","author":"Golper TA","year":"1998","journal-title":"Kidney Int Suppl"},{"key":"bibr38-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1159\/000060103"},{"key":"bibr39-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1345\/aph.17105"},{"key":"bibr40-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.07210.x"},{"key":"bibr41-aph.1L638","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199324050-00002"},{"key":"bibr42-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1007\/BF01700172"},{"key":"bibr43-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1097\/MCC.0b013e3282f0a3d3"},{"key":"bibr44-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.1998.v32.pm9708602"},{"key":"bibr45-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00613.x"},{"key":"bibr46-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70076-4"},{"key":"bibr47-aph.1L638","volume-title":"Unasyn (ampicillin\/sulbactam)","author":"Product information","year":"2003"},{"key":"bibr48-aph.1L638","volume-title":"AHFS: drug information","author":"McEvoy GK","year":"2008"},{"key":"bibr49-aph.1L638","volume-title":"The use of antibiotics\u2014a clinical review of antibacterial, antifungal and antiviral drugs","author":"Kucers A","year":"1997","edition":"5"},{"key":"bibr50-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.9.1470"},{"key":"bibr51-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.23.5.692"},{"key":"bibr52-aph.1L638","volume-title":"Azactam (aztreonam)","author":"Product information","year":"2007"},{"key":"bibr53-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.21.6.944"},{"key":"bibr54-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.24.2.252"},{"key":"bibr55-aph.1L638","volume-title":"The Merck index","author":"O'neil MJ","year":"2001","edition":"13"},{"key":"bibr56-aph.1L638","volume-title":"Maxipime (cefepime)","author":"Product information.","year":"2007"},{"key":"bibr57-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1990.149"},{"key":"bibr58-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.6.1853-1861.2003"},{"key":"bibr59-aph.1L638","volume-title":"Fortaz (ceftazidime)","author":"Product information.","year":"2007"},{"key":"bibr60-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.25.5.638"},{"key":"bibr61-aph.1L638","volume-title":"Pfizerpen (penicillin G potassium)","author":"Product information.","year":"2005"},{"key":"bibr62-aph.1L638","unstructured":"Aronoff GR Berns JS Brier ME, Drug prescribing in renal failure. 4th ed. Philadelphia, PA: American College of Physicians, 1999: 51."},{"key":"bibr63-aph.1L638","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-82-2-189"},{"key":"bibr64-aph.1L638","volume-title":"Zosyn (piperacillin\/tazobactam)","author":"Product information.","year":"2006"},{"key":"bibr65-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1992.5"},{"key":"bibr66-aph.1L638","volume-title":"Timentin (ticarcillin\/clavulanate)","author":"Product information.","year":"2004"},{"key":"bibr67-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.6.896"},{"key":"bibr68-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/17.suppl_C.57"},{"key":"bibr69-aph.1L638","volume-title":"Martindale","author":"Sweetman SC","year":"2002","edition":"33"},{"key":"bibr70-aph.1L638","doi-asserted-by":"publisher","DOI":"10.5414\/CNP67267"},{"key":"bibr71-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.11.3148-3155.2001"},{"key":"bibr72-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.05.004"},{"key":"bibr73-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1159\/000100864"},{"key":"bibr74-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-006-0397-x"},{"key":"bibr75-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/49.1.129"},{"key":"bibr76-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.6.1639-1644.2000"},{"key":"bibr77-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1177\/0091270004269796"},{"key":"bibr78-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1996.tb02978.x"},{"key":"bibr79-aph.1L638","doi-asserted-by":"publisher","DOI":"10.3109\/08860227709037663"},{"key":"bibr80-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1007\/BF01477408"},{"key":"bibr81-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/11.8.1582"},{"key":"bibr82-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050347"},{"key":"bibr83-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199801000-00021"},{"key":"bibr84-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/48.6.881"},{"key":"bibr85-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1007\/s001340050424"},{"key":"bibr86-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1186\/cc3993"},{"key":"bibr87-aph.1L638","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-008-1034-7"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1L638","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1L638","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:06:37Z","timestamp":1777374397000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1345\/aph.1L638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":87,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["10.1345\/aph.1L638"],"URL":"https:\/\/doi.org\/10.1345\/aph.1l638","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}